TITLE

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

AUTHOR(S)
Kraehn, G M; Utikal, J; Udart, M; Greulich, K M; Bezold, G; Kaskel, P; Leiter, U; Peter, R U
PUB. DATE
January 2001
SOURCE
British Journal of Cancer;1/1/2001, Vol. 84 Issue 1, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Amplification and overexpression of the c-myc gene have been associated with neoplastic transformation in a plethora of malignant tumours. We applied interphase fluorescence in situ hybridization (FISH) with a locus-specific probe for the c-myc gene (8q24) in combination with a corresponding chromosome 8 α-satellite probe to evaluate genetic alterations in 8 primary melanomas and 33 advanced melanomas and compared it to 12 melanocytic nevi, 7 safety margins and 2 cases of normal skin. Additionally, in metaphase spreads of 7 melanoma cell lines a whole chromosome 8 paint probe was used. We investigated the functionality of the c-myc gene by detecting c-myc RNA expression with RT-PCR and c-myc protein by immunohistochemistry. 4/8 primary melanomas and 11/33 melanoma metastases showed additional c-myc signals relative to the centromere of chromosome 8 copy number. None of the nevi, safety margins or normal skin samples demonstrated this gain. In 2/7 melanoma cell lines (C32 and WM 266-4) isochromosome 8q formation with a relative gain of c-myc copies and a loss of 8p was observed. The highest c-myc gene expression compared to GAPDH was found in melanoma metastases (17.5%). Nevi (6.6%) and primary melanomas (5.0%) expressed the c-myc gene on a lower level. 72.7% of the patients with c-myc extra copies had visceral melanoma metastases (UICC IV), patients without c-myc gain in 35.0% only. The collective with additional c-myc copies also expressed the gene on a significantly higher level. These results indicate that a c-myc gain in relation to the centromere 8 copy number might be associated with advanced cutaneous melanoma.
ACCESSION #
8876268

 

Related Articles

  • FISH assay may be useful monitor of TCC recurrence. Guttman, Cheryl // Urology Times;Dec2002, Vol. 30 Issue 12, p7 

    Investigates the use of fluorescence in situ hybridization (FISH) assay for monitoring recurrence of bladder cancer. Identification of the molecular tumor markers by diagnostic test; Causes of the cancer relapse; Classification of tumor by FISH assay.

  • Bladder Cancer Nabbed Earlier.  // Prevention;May2001, Vol. 53 Issue 5, p184 

    Reports on the development of a test, using fluorescence in situ hybridization (FISH), that can detect recurring bladder cancer earlier than existing tests.

  • Image Analysis of HER2 Immunohistochemical Staining. Minot, Douglas M.; Voss, Jesse; Rademacher, Susan; Lwin, Toe; Orsulak, Jessica; Caron, Bolette; Ketterling, Rhett; Nassar, Aziza; Chen, Beiyun; Clayton, Amy // American Journal of Clinical Pathology;Feb2012, Vol. 137 Issue 2, p270 

    Image analysis of the HER2 immunohistochemical IHC) stain can help determine which breast cancer patients may benefit from HER2-targeted therapy. We studied the concordance of HER2 IHC and fluorescence in situ hybridization (FISH) as well reproducibility of surgical pathologist (SP) and...

  • Serum HER-2 concentration in patients with primary breast cancer. Kong, S.-Y.; Kang, J. H.; Kwon, Y.; Kang, H.-S.; Chung, K.-W.; Kang, S. H.; Lee, D. H.; Ro, J.; Lee, E. S. // Journal of Clinical Pathology;Apr2006, Vol. 59 Issue 4, p373 

    Objective: To evaluate whether serum HER-2/neu (HER-2) concentration is a valid index of HER-2 status in women with primary breast cancer, and to establish a normal reference range for serum HER-2 concentration in Korean women. Methods: Serum HER-2 concentration was measured and...

  • Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal Treatment-Related Neuroendocrine Prostate Cancer. Mosquera, Juan Miguel; Beltran, Himisha; Kyung Park; MacDonald, Theresa Y.; Robinson, Brian D.; Tagawa, Scott T.; Perner, Sven; Bismar, Tarek A.; Erbersdobler, Andreas; Dhir, Rajiv; Nelson, Joel B.; Nanus, David M.; Rubin, Mark A. // Neoplasia;Jan2013, Vol. 15 Issue 1, p1 

    Neuroendocrine prostate cancer (NEPC), also referred to as anaplastic prostate cancer, is a lethal tumor that most commonly arises in late stages of prostate adenocarcinoma (PCA) with predilection to metastasize to visceral organs. In the current study, we explore for evidence that Aurora kinase...

  • Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer. Chughtai, Shaheen A; Crundwell, Malcolm C; Cruickshank, Neil RJ; Affie, Edwina; Armstrong, Sue; Knowles, Margaret A; Takle, Lyndsay A; Kuo, Michael; Khan, Neil; Phillips, Stewart MA; Neoptolemos, John P; Morton, Dion G // Oncogene;1/21/99, Vol. 18 Issue 3, p657 

    We have investigated interstitial deletions of chromosome 8 in 70 colorectal carcinomas and 11 colonic adenomas using 11 microsatellite markers, including eight spanning the centromeric region of chromosome 8p (p11.2-p12). Allelic loss or imbalance was observed in 38 (54%) cancers and four (36%)...

  • A novel multiple FISH array for the detection of genetic aberrations in cancer. Ruiyun Li; Zhenqiu Liu; Tao Fan; Feng Jiang // Laboratory Investigation (00236837);Jun2006, Vol. 86 Issue 6, p619 

    Interphase multicolor fluorescence in situ hybridization (IM-FISH) has great promise for improving cancer diagnosis because it can directly visualize multiple changes in chromosomes and gene copy number on a cell-to-cell basis. However, no more than four targets can be detected simultaneously by...

  • Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Barros-Silva, J D; Leitão, D; Afonso, L; Vieira, J; Dinis-Ribeiro, M; Fragoso, M; Bento, M J; Santos, L; Ferreira, P; Rêgo, S; Brandão, C; Carneiro, F; Lopes, C; Schmitt, F; Teixeira, M R // British Journal of Cancer;2/10/2009, Vol. 100 Issue 3, p487 

    The clinical significance of ERBB2 amplification/overexpression in gastric cancer remains unclear. In this study, we evaluated the ERBB2 status in 463 gastric carcinomas using immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH), and compared the findings with...

  • High Concordance Between Two Companion Diagnostics Tests. Jørgensen, Jan Trøst; Møller, Susanne; Rasmussen, Birgitte B.; Winther, Henrik; Schønau, Andreas; Knoop, Ann // American Journal of Clinical Pathology;Jul2011, Vol. 136 Issue 1, p145 

    The present study was done to investigate the concordance between the HER2 status measured by immunohistochemical analysis (HercepTest, DAKO, Carpinteria, CA) and fluorescence in situ hybridization (FISH; HER2 FISH pharmDx, DAKO) in a large study cohort (n = 681) of patients with high-risk...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics